On March 10, 2021, Invacare Corporation entered into a Ninth Amendment to Amended and Restated Revolving Credit and Security Agreement (the 'Credit Agreement Amendment'), by and among the Company, certain of the Company’s direct and indirect domestic, Canadian and European subsidiaries, the lenders party thereto, PNC Bank, National Association, as the agent for the lenders, and J.P. Morgan Europe Limited, as the European agent for the lenders, which amends the Amended and Restated Revolving Credit and Security Agreement, dated as of September 30, 2015 and amended as of February 16, 2016, May 3, 2016, September 30, 2016, November 30, 2016, June 7, 2017, November 13, 2019, May 29, 2020 and January 15, 2021 (as so amended, the “Credit Agreement”). The Credit Agreement Amendment provides for, among other things: the amendment of the negative covenant regarding indebtedness to permit the issuance of the 2026 Notes (as defined in Item 7.01 of this Current Report on Form 8-K); the amendment of various negative covenants to permit the capped call transactions to be entered into by the Company in connection with the issuance of the 2026 Notes; the amendment of the mandatory prepayment provision to eliminate the prepayment requirement that would otherwise be required upon the receipt of proceeds from the issuance of the 2026 Notes and the negative covenant regarding dividends to permit the issuance of certain equity interests, payment of interest on the 2026 Notes and certain payments to be made upon conversion of the 2026 Notes, as well as upon the exercise, settlement or termination of the related capped call transactions, so long as the Company is not, and would not after giving pro-forma effect to any such transaction be, in default under the Credit Agreement and has had adequate undrawn availability under its North American-based credit facility for the period required under the Credit Agreement; and the amendment of the prepayment of indebtedness covenant to permit without restriction the prepayment, repurchase, redemption, retirement or other acquisition of the Company’s 4.50% convertible senior notes due 2022 (the “2022 Notes”) and the Company’s 5.00% convertible senior notes due 2024 (the “2024 Notes”) (solely with respect to the 2024 Notes, not in excess of $50,000,000 in the aggregate during the term of the Credit Agreement) to the extent such prepayment, repurchase, redemption, retirement or other acquisition is made with the proceeds of the issuance of the 2026 Notes.